Published in J Infect Dis on February 16, 2004
Measuring nasal bacterial load and its association with otitis media. BMC Ear Nose Throat Disord (2006) 1.91
Direct detection of Nocardia spp. in clinical samples by a rapid molecular method. J Clin Microbiol (2005) 1.26
Screening of pneumococcal pneumonia by amplification of pneumolysin gene in children visiting hospitals in lahore, pakistan. Iran J Pediatr (2012) 0.80
Gel chromatographic characterization of proteins in mucous and serous middle ear effusions of patients with otitis media in comparison to serum proteins. Eur Arch Otorhinolaryngol (2007) 0.79
Moraxella catarrhalis Might Be More Common than Expected in Acute Otitis Media in Young Finnish Children. J Clin Microbiol (2016) 0.76
Diagnosis of Upper and Lower Respiratory Tract Bacterial Infections with the Use of Multiplex PCR Assays. Diagnostics (Basel) (2013) 0.75
Next-Generation Sequencing Combined with Specific PCR Assays To Determine the Bacterial 16S rRNA Gene Profiles of Middle Ear Fluid Collected from Children with Acute Otitis Media. mSphere (2017) 0.75
DNA-based culture-independent analysis detects the presence of group a streptococcus in throat samples from healthy adults in Japan. BMC Microbiol (2016) 0.75
Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics (2004) 4.74
Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun (2005) 1.96
Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis (2002) 1.81
Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest (2002) 1.66
Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother (2002) 1.63
Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage. Pediatr Infect Dis J (2005) 1.61
Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event. Heart Lung (2008) 1.47
Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med (2002) 1.33
Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer (2007) 1.32
Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 Birth Cohort study. Eur Heart J (2008) 1.32
Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections. Respir Med (2008) 1.31
Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis (2003) 1.29
Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis (2001) 1.25
A comparative study of the etiology of adult upper and lower respiratory tract infections in the community. Diagn Microbiol Infect Dis (2002) 1.23
The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol Psychiatry (2006) 1.13
C-reactive protein levels and sleep disturbances: observations based on the Northern Finland 1966 Birth Cohort study. Psychosom Med (2007) 1.12
Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Am J Obstet Gynecol (2008) 1.10
The value of nasopharyngeal culture in predicting the etiology of acute otitis media in children less than two years of age. Pediatr Infect Dis J (2006) 1.10
The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J (2004) 1.07
Risk of invasive pneumococcal infections among working age adults with asthma. Thorax (2010) 1.05
Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation (2003) 1.04
Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children. Vaccine (2009) 1.03
Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media. J Infect Dis (2007) 1.03
Seasonal patterns of viral and bacterial infections among children hospitalized with community-acquired pneumonia in a tropical region. Scand J Infect Dis (2010) 1.02
Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis (2002) 1.00
Low-grade, systemic inflammation in adolescents: association with early-life factors, gender, and lifestyle. Am J Epidemiol (2009) 0.99
Real-time quantitative PCR for the detection of Streptococcus pneumoniae in the middle ear fluid of children with acute otitis media. Mol Cell Probes (2002) 0.98
Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects. Scand J Infect Dis (2012) 0.97
Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler Thromb Vasc Biol (2002) 0.97
The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J (2008) 0.97
Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice. Antimicrob Agents Chemother (2005) 0.96
Pneumococcal carriage is more common in asthmatic than in non-asthmatic young men. Clin Respir J (2010) 0.96
Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media. J Infect Dis (2004) 0.95
Simkania negevensis infection among Brazilian children hospitalized with community-acquired pneumonia. J Infect (2009) 0.94
Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study. Clin Nutr (2007) 0.94
Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Scand J Infect Dis (2005) 0.92
Chlamydial antibodies and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.92
Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers. Clin Vaccine Immunol (2008) 0.91
Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae. Clin Vaccine Immunol (2008) 0.89
Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. J Infect Dis (2008) 0.89
Association of IL-6 and IL-6R gene polymorphisms with susceptibility to respiratory tract infections in young Finnish men. Hum Immunol (2010) 0.89
Procalcitonin is useful in identifying bacteraemia among children with pneumonia. Scand J Infect Dis (2010) 0.89
Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer (2003) 0.88
Relative frequency of Haemophilus influenzae type b pneumonia in Chinese children as evidenced by serology. Pediatr Infect Dis J (2002) 0.87
Chlamydial lipopolysaccharide (cLPS) is present in atherosclerotic and aneurysmal arterial wall--cLPS levels depend on disease manifestation. Cardiovasc Pathol (2009) 0.87
Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media. Clin Vaccine Immunol (2006) 0.87
Biofilm formation by Streptococcus pneumoniae isolates from paediatric patients. APMIS (2010) 0.87
Effect of xylitol and other carbon sources on Streptococcus pneumoniae biofilm formation and gene expression in vitro. APMIS (2010) 0.87
Presence of viral and bacterial pathogens in the nasopharynx of otitis-prone children. A prospective study. Int J Pediatr Otorhinolaryngol (2005) 0.86
Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice. Infect Immun (2005) 0.86
Proteomic analysis of Chlamydia pneumoniae-infected HL cells reveals extensive degradation of cytoskeletal proteins. FEMS Immunol Med Microbiol (2008) 0.86
Xylitol-supplemented nutrition enhances bacterial killing and prolongs survival of rats in experimental pneumococcal sepsis. BMC Microbiol (2008) 0.85
Antibodies to human heat shock protein 60, hypertension and dyslipidemia. A study of joint effects on coronary risk. Atherosclerosis (2003) 0.85
Trends and geographical variation in invasive pneumococcal infections in Finland. Scand J Infect Dis (2008) 0.85
In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model. Biochem Pharmacol (2005) 0.84
Clinical response to antibiotic therapy for community-acquired pneumonia. Eur J Pediatr (2004) 0.84
Nasal middle meatal specimen bacteriology as a predictor of the course of acute respiratory infection in children. Pediatr Infect Dis J (2006) 0.84
Microarray analysis of a Chlamydia pneumoniae-infected human epithelial cell line by use of gene ontology hierarchy. J Infect Dis (2008) 0.84
Diagnosis of Streptococcus pneumoniae and Haemophilus influenzae type b meningitis by identifying DNA from cerebrospinal fluid-impregnated filter paper strips. Pediatr Infect Dis J (2010) 0.84
Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland. Clin Diagn Lab Immunol (2005) 0.84
Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland. J Clin Microbiol (2011) 0.84
Risk factors for acute respiratory tract illness in military conscripts. Respirology (2008) 0.83
Microbial genome count in cerebrospinal fluid compared with clinical characteristics in pneumococcal and Haemophilus influenzae type b meningitis in children. Diagn Microbiol Infect Dis (2008) 0.83
The effect of proatherogenic microbes on macrophage cholesterol homeostasis in apoE-deficient mice. Microb Pathog (2011) 0.82
Corn mint (Mentha arvensis) extract diminishes acute Chlamydia pneumoniae infection in vitro and in vivo. J Agric Food Chem (2011) 0.82
Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient mice. Infect Immun (2009) 0.81
Chlamydial lipopolysaccharide is present in serum during acute coronary syndrome and correlates with CRP levels. Atherosclerosis (2006) 0.81
Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice. Antimicrob Agents Chemother (2004) 0.81
Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice. Int J Antimicrob Agents (2007) 0.81
Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension. Hypertens Pregnancy (2008) 0.80
Comparison of polymerase chain reaction methods, in situ hybridization, and enzyme immunoassay for detection of Chlamydia pneumoniae in atherosclerotic carotid plaques. Diagn Microbiol Infect Dis (2008) 0.80
Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study. Scand J Infect Dis (2014) 0.80
Serum C-reactive protein and Chlamydia trachomatis antibodies in preterm delivery. Obstet Gynecol (2005) 0.79
Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease. Innate Immun (2008) 0.79
Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum. Scand J Infect Dis (2009) 0.79
Real-time pneumolysin polymerase chain reaction with melting curve analysis differentiates pneumococcus from other alpha-hemolytic streptococci. Diagn Microbiol Infect Dis (2005) 0.79
Asthmatic persons are prone to the persistence of Chlamydia pneumoniae antibodies. Diagn Microbiol Infect Dis (2007) 0.79
Inhibitory effect of heparan sulfate-like glycosaminoglycans on the infectivity of Chlamydia pneumoniae in HL cells varies between strains. Microbes Infect (2006) 0.78
Rapamycin can inhibit the development of Chlamydia pneumoniae, which might partly contribute to the prevention of in-stent restenosis. Cardiovasc Drugs Ther (2010) 0.78
Isolation of pneumococcal DNA from nasopharyngeal samples for real-time, quantitative PCR: comparison of three methods. Mol Diagn (2003) 0.78
Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods. Diagn Microbiol Infect Dis (2006) 0.78
Development and validation of a time-resolved fluorometric immunoassay for screening of antichlamydial activity using a genus-specific europium-conjugated antibody. Anal Biochem (2004) 0.78
Serologically indicated pneumococcal pneumonia in children: a population-based study in primary care settings. APMIS (2003) 0.78
Infectious aetiologies in elderly patients hospitalised with non-pneumonic lower respiratory tract infection. Age Ageing (2003) 0.77
Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue. Vaccine (2002) 0.77
Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro. J Antibiot (Tokyo) (2011) 0.77
Low mannose-binding lectin levels and MBL2 gene polymorphisms associate with Chlamydia pneumoniae antibodies. Innate Immun (2009) 0.77
Smoking status interacts with the association between mannose-binding lectin serum levels and gene polymorphism and the carriage of oropharyngeal bacteria. Hum Immunol (2010) 0.77
Training improves physical fitness and decreases CRP also in asthmatic conscripts. J Asthma (2008) 0.77
Novel enzyme immunoassay utilizing lipopolysaccharide-binding protein as a capture molecule for the measurement of chlamydial lipopolysaccharide in serum. Diagn Microbiol Infect Dis (2005) 0.77
Methodological aspects affecting the infectivity of Chlamydia pneumoniae in cell cultures in vitro. J Microbiol Methods (2005) 0.76
The effect of proatherogenic pathogens on adipose tissue transcriptome and fatty acid distribution in apolipoprotein E-deficient mice. BMC Genomics (2013) 0.76
Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit. Clin Diagn Lab Immunol (2003) 0.76
Selective cyclooxygenase inhibitors prevent the growth of Chlamydia pneumoniae in HL cells. Int J Antimicrob Agents (2008) 0.76
Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial. Pediatr Infect Dis J (2015) 0.76
Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect. Clin Infect Dis (2004) 0.75